Search Results - I. Z. Gaydukova

Refine Results
  1. 1
    Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system

    Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system by A. V. Rudakova, I. Z. Gaydukova

    Published 2025-02-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Heart rate variability in patients with psoriatic arthritis: associations with systemic inflammation and traditional cardiovascular risk factors

    Heart rate variability in patients with psoriatic arthritis: associations with systemic inflammation and traditional cardiovascular risk factors by I. Z. Gaydukova, D. A. Poddubnyi, A. P. Rebrov

    Published 2011-04-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    VALIDATION OF THE EQ-5D-5L VERSION IN RUSSIA

    VALIDATION OF THE EQ-5D-5L VERSION IN RUSSIA by A. I Akulova, I. Z. Gaydukova, A. P. Rebrov

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs

    The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs by A. P. Rebrov, I. A. Romanova, I. Z. Gaydukova

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis

    Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis by A. P. Rebrov, I. A. Romanova, I. Z. Gaydukova

    Published 2016-06-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis

    The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis by V. I. Mazurov, E. A. Trofimov, I. Z. Gaydukova

    Published 2018-04-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Remission in ankylosing spondylitis and axial spondyloarthritides: A modern understanding of the problem

    Remission in ankylosing spondylitis and axial spondyloarthritides: A modern understanding of the problem by I. Z. Gaydukova, A. P. Rebrov, A. A. Shuvalova

    Published 2016-03-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Changing the concept of spondyloarthritis: Characteristics of teaching when changing the paradigm in a particular area of medical knowledge

    Changing the concept of spondyloarthritis: Characteristics of teaching when changing the paradigm in a particular area of medical knowledge by I. Z. Gaydukova, V. A. Sergeeva, A. P. Rebrov

    Published 2017-04-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Validation of the Russian-language version of the ASAS Health Index

    Validation of the Russian-language version of the ASAS Health Index by A. I. Akulova, A. P. Rebrov, Sh. Erdes, I. Z. Gaydukova

    Published 2019-07-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Repeated short cycles of nonsteroidal anti-inflammatory drugs and kidney injury in patients with spinal degenerative-dystrophic diseases

    Repeated short cycles of nonsteroidal anti-inflammatory drugs and kidney injury in patients with spinal degenerative-dystrophic diseases by D. M. Bichurina, I. Z. Gaydukova, D. А. Patrikeeva, A. P. Rebrov

    Published 2018-09-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Quality of life in spondyloarthritis patients receiving biological therapy

    Quality of life in spondyloarthritis patients receiving biological therapy by A. I. Akulova, K. D. Dorogoikina, I. Z. Gaydukova, A. P. Rebrov

    Published 2019-10-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Efficacy and safety of biologics for the treatment of ankylosing spondylitis: systematic literature review and network meta-analysis of treatments registered in the Russian Federation

    Efficacy and safety of biologics for the treatment of ankylosing spondylitis: systematic literature review and network meta-analysis of treatments registered in the Russian Federat... by T. V. Dubinina, I. Z. Gaydukova, V. D. Sokolova, V. V. Mladov, D. G. Tolkacheva

    Published 2021-01-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Etanercept in axial spondyloarthritis – treatment efficacy

    Etanercept in axial spondyloarthritis – treatment efficacy by I. Z. Gaydukova, O. V. Inamova, R. R. Samigullina, A. L. Chudinov, A. S. Bychkova

    Published 2022-03-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    LIVER FUNCTION CHANGES IN PATIENTS WITH SPONDYLOARTHRITIS TAKING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS OVER A LONG PERIOD: RESULTS OF A 10-YEAR PROGRESS PROSPECTIVE STUDY

    LIVER FUNCTION CHANGES IN PATIENTS WITH SPONDYLOARTHRITIS TAKING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS OVER A LONG PERIOD: RESULTS OF A 10-YEAR PROGRESS PROSPECTIVE STUDY by A. P. Rebrov, I. Z. Gaydukova, A. V. Aparkina, E. V. Khondkarian, A. I. Akulova

    Published 2016-12-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis

    Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis by T. V. Dubinina, I. Z. Gaydukova, N. А. Sableva, K. V. Sapozhnikov, V. D. Sokolova, D. G. Tolkacheva

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Difficulties in diagnosis and treatment of adult-onset Still's disease concurrent with pericardial effusion as a leading clinical manifestation

    Difficulties in diagnosis and treatment of adult-onset Still's disease concurrent with pericardial effusion as a leading clinical manifestation by V. Yu. Myachikova, A. L. Maslyansky, I. Z. Gaydukova, A. N. Novikova, D. V. Karpova, E. V. Shlyakhto

    Published 2016-03-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    The Level of IgA Antibodies to CD74 in Patients with Spondyloarthritis and Degenerative-Dystrophic Diseases of the Spine

    The Level of IgA Antibodies to CD74 in Patients with Spondyloarthritis and Degenerative-Dystrophic Diseases of the Spine by A. P. Rebrov, I. Z. Gaydukova, A. V. Aparkina, M. A. Korolev, K. N. Safarova, K. D. Dorogoikina, D. M. Bichurina

    Published 2022-08-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis

    Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis by V. I. Mazurov, I. Z. Gaydukova, E. A. Vasilenko, E. A. Vasilenko, S. V. Lapin, S. V. Lapin, I. V. Kholopova, M. A. Korolev

    Published 2021-01-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study

    Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study by T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaydukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Eremeeva, M. A. Morozova

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Efficacy of netakimab in key psoriatic arthritis domains: 54-week results from the phase III BCD-085-8/PATERA study

    Efficacy of netakimab in key psoriatic arthritis domains: 54-week results from the phase III BCD-085-8/PATERA study by T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaydukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Zinkina-Orikhan, Yu. A. Sevastyanova, A. V. Eremeeva

    Published 2021-03-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: